A recently published essay collection curated by Malaria No More UK and the ONE Campaign, makes the case for the next UK government to continue its support for the life-saving work of multilateral global health mechanisms like Gavi, The Vaccine Alliance and The Global Fund to fight AIDs, Tuberculosis and Malaria, and Unitaid.

The collection features essays from a diverse range of British and international voices, including a piece by IVCC CEO, Justin McBeath where he highlights the critical role of Product Development Partnerships (PDPs) – such as IVCC – in bringing forward life-changing innovations for the elimination of diseases such as malaria. In the essay he writes:

PDPs serve as catalysts for innovation and progress. They bridge the gap between scientific discovery and tangible solutions, driving research and development efforts that address […] health threats.   To eradicate malaria for good, PDPs like IVCC deserve support, so they can continue to deliver the innovative tools that can finally put malaria into retreat.

To read Justin’s full essay and all the contributions by Gavi and The Global Fund; Labour MPs and parliamentary candidates; scientists and researchers from the London School of Hygiene and Tropical Medicine, Medicines for Malaria Venture; and youth activists and community health workers from endemic countries, visit the Malaria No More UK website to download the report.

Our Africa Regional Coordinator, Andrew Saibu, contributed an editorial in the latest edition of the South African Pest Control Association’s (SAPCA), Pest News.

In the piece, Andrew makes the case for the role of the private sector, and mining companies in particular, in supporting malaria control throughout sub-Saharan Africa.

The Pest News February 2024* instalment is available via this download. Andrew’s editorial is available from page nine onward: Mines against malaria.

*with thanks to SAPCA.

The IVCC Annual Report 2022-2023 has been published.

The report showcases IVCC’s work to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance. With activities across the globe and spanning research and development and market access, we are accelerating the process from innovation to impact.

The report is a reminder of the importance of collaborative working and the progress laid out in it is testament, too, to the commitment of our partners from industry, academia, the public sector, and advocacy. We are grateful for the support of all our funders, who make life-saving vector control possible.

Earlier in 2023 IVCC embarked upon a strategic review to assess and realign priorities to ensure that we are focusing on the unmet needs that will have the most significant impact against vector-borne disease. The annual report outlines IVCC’s strategic priorities going forward.

Another highlight is a section on climate change and the dramatic impact it is having on vector-borne disease transmission, demanding new policies, tools and approaches.

“At this pivotal time for global health, I call upon the wider global community to ensure that, as IVCC and its partnerships continue with their missions, appropriate political will and funding, facilitates and strengthens our collective efforts to eradicate malaria and the neglected tropical diseases that afflict the most vulnerable members of society.”

Sherwin Charles, Chair, Board of Trustees, IVCC.

For more information or to request a physical copy please provide your full name and postal address to Laura Roberts on laura.roberts@ivcc.com.